Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
SOLV
↓ PDF (Pro)Solventum Corporation Common Stock
HealthcareMedical Instruments & SuppliesUnited StatesNYSE
$68.58
+1.69%today
MKT CAP
$12.1B
-0.9% · 1Y
Earnings History
+9.7%
+16.3%
+4.7%
+5.0%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$68.58
Low
$60.00
Analyst Mean
$84.08
High
$105.00
12 analystsBuy
Full Financials
Trailing P/E8.8x
Forward P/E10.3x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+0.5%
5y Revenue CAGR-
5y Earnings CAGR+7.5%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership15.0%
Institutional Ownership74.3%
Short % of Float4.33%
Days to Cover4.5d
1 Week+1.5%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| WEILAND JOHN H | Director | Other | 3,403 | - | - | 2026-04-30 |
| COX CARRIE SMITH | Director | Other | 4,916 | - | - | 2026-04-30 |
| MAY KAREN J | Director | Other | 3,403 | - | - | 2026-04-30 |
| EISENBERG GLENN A | Director | Other | 3,403 | - | - | 2026-04-30 |
| HARRIS BERNARD A JR | Director | Other | 3,403 | - | - | 2026-04-30 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Vanguard Group Inc | institution | 9.82% | $1.22B | -0.55% | 2025-12-31 |
| Independent Franchise Partners, LLP | institution | 8.86% | $1.10B | +19.04% | 2025-12-31 |
| Blackrock Inc. | institution | 5.94% | $0.74B | +0.73% | 2025-12-31 |
| Trian Fund Management, LP | institution | 4.75% | $0.59B | -2.67% | 2025-12-31 |
| State Street Corporation | institution | 3.66% | $0.45B | +2.00% | 2025-12-31 |
| Davis Selected Advisers | institution | 3.59% | $0.45B | +12.73% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.68% | $0.33B | -0.10% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 2.65% | $0.33B | +19.95% | 2025-12-31 |
| Boston Partners | institution | 2.36% | $0.29B | -11.77% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | fund | 2.14% | $0.27B | +2.25% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | fund | 1.93% | $0.24B | -4.23% | 2025-12-31 |
| Invesco Ltd. | institution | 1.69% | $0.21B | +3.40% | 2025-12-31 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | fund | 1.59% | $0.20B | -7.43% | 2026-03-31 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | fund | 1.48% | $0.18B | +23.56% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | fund | 1.24% | $0.15B | -3.52% | 2025-12-31 |
| Diamond Hill Capital Management Inc | institution | 1.22% | $0.15B | +152.24% | 2025-12-31 |
| iShares Trust-iShares Core S&P 500 ETF | fund | 1.09% | $0.14B | +0.98% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | fund | 1.09% | $0.13B | +0.35% | 2026-03-31 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | fund | 0.99% | $0.12B | -1.24% | 2026-03-31 |
| DAVIS NEW YORK VENTURE FUND INC-Davis New York Venture Fund | fund | 0.91% | $0.11B | +0.00% | 2026-01-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| COO | $11.9B | 62 | 30.4 | 12.2 | - | - | - | - | 0.00% |
| ALGN | $12.4B | 59 | 28.3 | 13.6 | 12.4 | 10.8% | 70% | 2.80 | 0.00% |
| BAX | $8.8B | 50 | - | 8.4 | 8.6 | -15.0% | 35% | 161.02 | 118.00% |
| ATR | $7.9B | 60 | 21.0 | 19.6 | - | - | - | - | 1.54% |
| RGEN | $7.2B | 5 | 147.1 | 50.2 | - | - | - | - | 0.00% |
| WST | $22.2B | 66 | 41.3 | 32.3 | 24.2 | 19.1% | 36% | 10.73 | 0.29% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for SOLV.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.